Resources Investment Advisors, Llc. Bluebird Bio, Inc. Transaction History

Resources Investment Advisors, Llc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$64.44 - $104.11 $5,799 - $9,369	-90 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$59.1 - $93.26 $41,133 - $64,908	-696 Reduced 88.55%	90 $9,000
Q3 2018 Nov 07, 2018	BUY	$88.86 - $117.49 $49,850 - $65,911	561 Added 249.33%	786 $115,000
Q2 2018 Aug 15, 2018	BUY	$99.64 - $127.59 $22,419 - $28,707	225 New	225 $35,000
Q3 2017 Nov 13, 2017	SELL	$57.74 - $91.42 $11,836 - $18,741	-205 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	205	205 $22,000

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $677M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.